USPTO serial 88665688
DIGIHEALTH
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Oct 4, 2022
- Examiner
- FLOWERS, JAY K
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with DIGIHEALTH?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Heather E. Balmat
Heather E. Balmat BALMAT LAW, PLLC977 SEMINOLE TRAIL, #342CHARLOTTESVILLE, VA 22901UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable artificial intelligence and machine learning software for use in clinical medical assessments, health commissioning and health technology by analyzing patient reported outcome measures reported via a downloadable mobile application and to contribute health data for personalized outcomes research, to inform the quality of care and interventions received, and to inform outcome-based pricing agreements; downloadable artificial intelligence software, namely, a downloadable mobile application, which automates the processing and management of feedback reported directly by patients and informs performance based pricing agreements for health technologies and healthcare services; downloadable artificial intelligence software for use in clinical medical assessments, health commissioning and health technology by analyzing patient reported outcome measures reported via a downloadable mobile application and to contribute health data for personalized outcomes research, to inform the quality of care and interventions received, and to inform outcome-based pricing agreements; downloadable artificial intelligence software for analysis of patient reported outcome measures and their impact on clinical medical assessment, health commissioning and health technology and to contribute health data for personalized outcomes research, to inform the quality of care and interventions received, and to inform outcome-based pricing agreements; downloadable artificial intelligence software for healthcare, namely, downloadable artificial intelligence software for use in analyzing patient reported outcome measures and their impact on clinical medical assessment, health commissioning and health technology and to contribute health data for personalized outcomes research, to inform the quality of care and interventions received, and to inform outcome-based pricing agreements; downloadable AI software for use in clinical medical assessments, health commissioning and health technology by analyzing patient reported outcome measures reported via a downloadable mobile application and to contribute health data for personalized outcomes research, to inform the quality of care and interventions received, and to inform outcome-based pricing agreements; downloadable application development software for the management, collection and processing of patient reported outcome measures, including patient engagement capabilities and in-built reward mechanisms for anonymized data sharing; downloadable application server software for the management, collection and processing of patient reported outcome measures, including patient engagement capabilities and in-built reward mechanisms for anonymized data sharing; downloadable application simulation software for creation and deployment of patient-reported outcome surveys and questionnaires to inform performance-based pricing agreements; downloadable application software for use in clinical medical assessments, health commissioning and health technology by analyzing patient reported outcome measures reported via a downloadable mobile application and to contribute health data for personalized outcomes research, to inform the quality of care and interventions received, and to inform outcome-based pricing agreements; downloadable application software for cloud computing services; downloadable artificial intelligence and machine learning software; downloadable artificial intelligence software for analysis | ACTIVE | — |
| 042 | Scientific advisory services in the field of value-based healthcare; scientific analysis of healthcare and patient reported outcomes; scientific and industrial research in the field of data mapping and calculation of health state utility values in accordance to data collected from patient-reported outcome measure instrument; scientific computer programming services; scientific consultancy; scientific research; scientific research and analysis; scientific research and development; scientific research conducted using databases; scientific research for medical purposes; scientific research for medical purposes in the area of cancerous diseases; scientific research in the field of pharmacy; scientific research relating to biology; Scientific research relating to chemistry; scientific research services; scientific services, namely, value-based healthcare implementation management and research relating thereto; scientific technological services, namely, value based healthcare data management; services for designing computer software; services for maintenance of computer software; services for the design of computer systems; services for the provision of technological information; services for updating computer software; software as a service featuring software for value-based healthcare implementation; software as a service (SaaS) featuring software for value-based healthcare management; software as a service (SaaS) featuring software for deep learning; software as a service (SaaS) featuring software for deep neural networks; software as a service (SaaS) featuring software for machine learning; software as a service (SaaS) featuring software platforms for graphic design; software as a service (SaaS) services featuring software for value-based healthcare management; software as a service (SaaS) services featuring software for machine learning, deep learning and deep neural networks; software consultancy services; software consulting services; software design; software design and development; computer software design; software design for others; software development; software development in the framework of software publishing; software development, programming and implementation; software development services; software engineering; software engineering services; maintenance of computer software; research and development of computer software | ACTIVE | — |
| 045 | licensing industrial property rights; licensing of computer programs; licensing of computer software; licensing of databases; licensing of industrial property rights; licensing of industrial property rights and copyright; licensing of intellectual property; licensing of intellectual property and copyright; licensing of intellectual property rights; licensing of patent applications; licensing of patents; licensing of research and development; licensing of software; licensing of technology; licensing of trademarks; licensing services, namely, licensing of downloadable software systems for value based healthcare management and implementation | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Digipharm Ltd.
- Other trademarks owned by Digipharm Ltd.
- Other trademarks owned by Digipharm Ltd.
- Other trademarks in Class 009
- Other trademarks in Class 042
- Other trademarks in Class 045
- Similar marks named DIGIHEALTH
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 4, 2022 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Oct 4, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 31, 2022 | DP1B | 1(B) BASIS DELETED; PROCEED TO REGISTRATION | — |
| Aug 31, 2022 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Aug 25, 2022 | IUCN | NOTICE OF ALLOWANCE CANCELLED | — |
| Aug 25, 2022 | D1BR | TEAS DELETE 1(B) BASIS RECEIVED | — |
| Jul 13, 2022 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jul 11, 2022 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jul 11, 2022 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jul 11, 2022 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jan 11, 2022 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Nov 16, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 16, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 27, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 12, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 6, 2021 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Oct 6, 2021 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Oct 6, 2021 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Oct 6, 2021 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Oct 2, 2021 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Oct 2, 2021 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Oct 2, 2021 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Sep 3, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 3, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 3, 2021 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Mar 4, 2021 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Mar 4, 2021 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Mar 4, 2021 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Sep 4, 2020 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Sep 4, 2020 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Sep 4, 2020 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Aug 26, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 26, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 25, 2020 | ALIE | ASSIGNED TO LIE | — |
| Aug 4, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 4, 2020 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 4, 2020 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 4, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 29, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 29, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 26, 2019 | NWAP | NEW APPLICATION ENTERED | — |